Johnson & Johnson MedTech acquires Laminar Inc. for an upfront $400 million
NEW BRUNSWICK: Johnson & Johnson MedTech, a division of Johnson & Johnson that focuses on medical intervention solutions, announced today that it has completed the acquisition of Laminar Inc., a privately-held medical device company that specializes in eliminating the left atrial appendage (LAA) in patients with non-valvular atrial fibrillation (AFib). The deal was worth $400…